Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte versus Voluven during adult cardiac surgery
ChiCTR-IPR-15006241Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University
- Start
- May 2015
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of hetastarch and Volulyte in rheumatic heart disease (RHD) (2 arms), sponsored by Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University. Primary endpoints: Blood coagulation function, Liver function and 1 more. Planned start May 2015; status: not yet recruiting.
02
Drugs
hetastarchVolulyte
03
Conditions
rheumatic heart disease (RHD)
Beyond the preview
Go deeper on ChiCTR-IPR-15006241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006241.